Liso-Cel Maintains Longer-Term Responses in Pretreated Relapsed/Refractory CLL/SLL
Tatyana Feldman, MD, highlights updated data for liso-cel in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Source: onclive.com
Stay updated with breaking news from Iso Cel . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tatyana Feldman, MD, highlights updated data for liso-cel in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.